We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

133 hedge funds and large institutions have $1.05B invested in Array Biopharma Inc in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

79% more capital invested

Capital invested by funds: $586M → $1.05B (+$464M)

57% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 35

32% more call options, than puts

Call options by funds: $25.1M | Put options by funds: $19M

9% more funds holding

Funds holding: 122 → 133 (+11)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
133
Holders Change
+11
Holders Change %
+9.02%
% of All Funds
3.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
27
Increased
55
Reduced
35
Closed
15
Calls
$25.1M
Puts
$19M
Net Calls
+$6.1M
Net Calls Change
+$5.59M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$52.1M
2
BBA
Baker Bros. Advisors
New York
+$30.1M
3
O
OrbiMed
New York
+$14.1M
4
Invesco
Invesco
Georgia
+$12.9M
5
Millennium Management
Millennium Management
New York
+$11.9M

Top Sellers

1
BI
BVF Inc
California
-$16.8M
2
BA
BlackRock Advisors
Delaware
-$8.27M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.72M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.27M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
126
Creative Planning
Kansas
$18K -$14.2K -2,000 -45%
CCMH
127
Cornerstone Capital Management Holdings
New York
$15K +$14.2K +2,000 New
FCCM
128
First City Capital Management
Georgia
$14.7K – – –
US Bancorp
129
US Bancorp
Minnesota
$13K -$7.51K -1,055 -38%
Zurich Cantonal Bank
130
Zurich Cantonal Bank
Switzerland
$4K +$4.26K +598 New
DADC
131
D.A. Davidson & Co
Montana
$2K – – –
ARMC
132
American Research & Management Company
Massachusetts
$1K – – –
Manulife (Manufacturers Life Insurance)
133
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$655 +$39.1K +5,498 +7%
Point72 Asset Management
134
Point72 Asset Management
Connecticut
– -$4.27M -903,300 Closed
KCM
135
Kennedy Capital Management
Missouri
– -$3.14M -663,662 Closed
QF
136
QVT Financial
New York
– -$1.71M -361,722 Closed
HCM
137
Highbridge Capital Management
New York
– -$925K -195,712 Closed
PI
138
Putnam Investments
Massachusetts
– -$916K -193,585 Closed
PWLP
139
Prio Wealth Limited Partnership
Massachusetts
– -$283K -60,000 Closed
ZIM
140
Zacks Investment Management
Illinois
– -$242K -51,187 Closed
PAM
141
Princeton Alpha Management
New Jersey
– -$122K -25,785 Closed
Janney Montgomery Scott
142
Janney Montgomery Scott
Pennsylvania
– -$107K -22,600 Closed
CPC
143
Cookson Peirce & Co
Pennsylvania
– -$61K -12,990 Closed
M&T Bank
144
M&T Bank
New York
– -$49K -10,189 Closed
FTIOP
145
Fiduciary Trust International of Pennsylvania
Pennsylvania
– -$47K -10,000 Closed
NPC
146
National Planning Corporation
California
– -$13.6K -3,000 Closed
Envestnet Asset Management
147
Envestnet Asset Management
Illinois
– -$7K -1,384 Closed
RC
148
RegentAtlantic Capital
New Jersey
– -$4.73K -1,000 Closed
2 3 4 5
6

ARRY Hedge Fund Activity: Q1 2015 in Review

133 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q1 2015, worth a combined $1.05B — up 79% from $586M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ARRY positions and 15 closed out — a net gain of 12 holders — while 55 added to existing stakes and 35 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $52.1M. The largest seller was BVF Inc, cutting an estimated $16.8M.

  • 133 institutional investors held Array Biopharma Inc (ARRY) as of Q1 2015, up from 122 in Q4 2014.
  • Funds reported $1.05B of Array Biopharma Inc stock for Q1 2015, up 79% quarter-over-quarter.
  • 27 funds opened new Array Biopharma Inc positions in Q1 2015 and 15 closed out, a net change of +12 holders.
  • The largest Array Biopharma Inc buyer in Q1 2015 was Fidelity Investments, an estimated $52.1M added.
  • The largest Array Biopharma Inc seller in Q1 2015 was BVF Inc, an estimated $16.8M sold.

Based on aggregated 13F filings for Q1 2015.